Gilles Divita

Company: Divincell / Aanastra

Job title: Co-Founder & Chief Executive Officer

Seminars:

A Novel Safe & Re-Dosable Peptide-Based Nanoparticle Platform for Targeted Delivery 11:30 am

Designing and using AI-driven optimization of a peptide-vector for cell membrane selectivity and cellular uptake Defining safety and characterization of peptide-based nanoparticles for extrahepatic delivery of different payloads including peptide, protein and RNA Applying a peptide-based nanoparticle platform for systemic targeted delivery of therapeutic mRNA: T cell engineering and tumor selectivityRead more

day: Day Two